FDA Permits Drug for Treatment of Inhalational Anthrax Cases

The US Food and Drug Administration has given green signal to Anthrasil, a drug meant to treat patients infected by inhalational anthrax.

The FDA said the drug officially named as Anthrax Immune Globulin Intravenous (Human) will be used for treatment in combination with currently used antibacterial drugs. It is said that when patient starts exhibiting symptoms of the disease then it is considered to be too late.

But Anthrasil has been developed in such a way it would help anthrax victims even after they have started displaying symptoms. Inhalational anthrax is a rare form of the disease, which can happen after exposure to infected animals or through contaminated animal products.

Smoking can affect Unborn Babies: Study

Researchers have released some images, showing a baby grimacing in uterus immediately when the child's mother lights up a cigarette. Durham and Lancaster universities in the UK captured these four-dimensional ultrasound scans as part of a pilot study.

Lancaster University's professor Brian Francis said, "This is yet further evidence of the negative effects of smoking in pregnancy. Technology means we can now see what was previously hidden, revealing how smoking affects the development of the fetus in ways we did not realize".

The preliminary findings of the study stem from an analysis of 80 4-D ultrasound scans of 20 healthy fetuses. Out of these, four were carried by mothers who smoked an average of 14 cigarettes per day, whereas the remaining 16 were carried by nonsmokers.

Scientists collect information about DNA of Icelanders

Scientists have gathered more details about the DNA of Icelanders as compared to any other nation on earth. Genomes of more than 1 in every 100 people in the country have been sequenced by scientists at Amgen's DeCode Genetics.

Nordic quest of the company follows a theory that mutant genes could reveal the secrets of future medicine by finding uncommon human outliers whose DNA protects them against ailments that others suffer.

Ban on using terms ‘Climate Change’, ‘Global Warming’ Irresponsible: Tyson

Neil DeGrasse Tyson, American astrophysicist and science communicator, is known for his knowledge about science and space. The cosmologist has revealed many interesting facts about science. Now, the famous astrophysicist has commented on Florida ban on saying 'climate change' and 'global warming'. According to Tyson, the ban by the state is irresponsible.

Earlier, Florida governor Rick Scott said that he has not ordered to stop using the terms. In Sarasota, while addressing a crowd at Ringling College, Tyson said that it is not possible to 'cherrypick' science. According to Tyson, global warming cannot be avoided for political reasons.

Study suggests that Healthy, beetle-kill Forests pose similar Risks

According to a new study conducted by researchers from the University of Colorado, large wildfires are no more likely in forests hit by beetle infestation than in those that are healthy.

To conduct the study, which has been published in the Proceedings of the National Academy of Sciences, the researchers used federal maps. During the study, they covered the areas of western forests that were burned by wildfire three times. They also tried to figure out which areas of the location had been infested by pine beetles. According to the researchers, the areas with beetle-kill accounted for about 46% of the total region burned.

Bill Gates comments on Steve Jobs

The new Steve Jobs autobiographical book 'Becoming Steve Jobs' tells about Microsoft founder Bill Gates' opinions regarding Jobs. Gates has admired Jobs and showed a lot of respect for him. However, he still spoke about the intellect of Jobs, and also the mistakes committed by him. Gates also spoke about Jobs's showmanship.

According to Gates, "I was never in his league. I mean, it was just amazing to see how precisely he would rehearse. And if he's about to go onstage, and his support people don't have the things right, you know, he is really, really, tough on them".

Pages

News in Focus

Pricol Share Price Target at Rs 935: Axis Securities

Axis Securities has kept its BUY call on Pricol Ltd with an unchanged target price of Rs 935, about 28% above the Nov. 5 closing price of Rs 728.

Mahindra & Mahindra Share Price Target at Rs 4,387: BOB Capital Markets

BOB Capital Markets has retained its BUY rating on Mahindra & Mahindra but trimmed its target price to Rs 4,387 from Rs 4,530, still implying about 40% upside from the Rs 3,128 market price.

ICICI Securities has maintained its BUY rating on Swiggy but cut its target price to Rs 400 from Rs 520, still implying about 90% upside from the Rs 211 market price.

Stylam Industries Share Price Target at Rs 3,750: ICICI Direct

ICICI Direct, the retail research arm of ICICI Securities, has maintained its BUY call on Stylam Industries with a revised 12-month target price of Rs 3,750, about 21% above the current market pric

Saregama Share Price Target at Rs 740: ICICI Direct

ICICI Direct, the retail research arm of ICICI Securities, has reiterated its BUY call on Saregama India with a 12-month target price of Rs 740, about 16% above the Rs 638 market price, after the R

Cera Sanitaryware Share Price Target at Rs 6,437: BOB Capital Markets

BOB Capital Markets has maintained its BUY rating on Cera Sanitaryware with a target price of Rs 6,437, implying about 34% upside from the Nov. 5 closing price of Rs 4,802.